At Veramed, our team of seasoned, multi-skilled global experts are committed to providing comprehensive support throughout your clinical study journey.
Strategic & Technical Consulting Services
Statistical Design &
Support
Emily Wood is the Head of Statistical Consultancy at Veramed, with over 20 years of experience specializing in statistical design and support within the pharmaceutical industry. She has extensive expertise across a broad range of therapeutic areas, including Oncology, Respiratory, and Immunology. Emily has a proven ability to lead and design innovative statistical strategies throughout all phases of clinical trials, ensuring robust data analysis and interpretation that supports decision-making.
Known for her collaborative and adaptable approach, Emily excels in providing tailored statistical consultancy on a global scale, working closely with clients and cross-functional teams to deliver precise, actionable insights. As a mentor to younger Statisticians, she perfectly blends her proficiency for flexible, efficient statistical analysis support with a people-driven and collaborative approach. Under her leadership, projects are consistently delivered on time and within budget, while exceeding client expectations.
Technology, Standards
& Automation
With over 25 years’ experience developing software, Stuart is responsible for driving the development and adoption of software, tools and techniques that optimize Veramed's clinical trial analysis projects.
Data Visualization &
Real-time Data
While Steve has more than 25 years of experience in working on medicine developement projects within the pharmceutical industry, it is his specialist knowledge and experience in study design and simulation, estimands and quantitive decision-making, alongside his passion for data visualization as an exceptional tool for communication that really adds value to any project.
Steve has worked across various therapeutic areas including rare diseases, respiratory, nephrology, immuno-inflammation and neurosciences, providing project-level statistical leadership, including for a phase III schizophrenia study. He also has experience in preparing briefing documents for FDA Type 2 meetings, successful submission and regulatory approvals (FDA and PDMA) and face to face meetings with MHRA. Steve is also an active member of the PSI data visualiation Special Interest Group (vis-SIG).
Steve achieved his BSc (Hons) in Biochemistry from the University of Bristol, an MPhil in Biochemistry from University College London, and an MSc. in Applied Statistics from Birkbeck College.
Functional Service Provider
Debra is responsible for Veramed's Biometrics FSP offering in North America. She excels in building and maintaining strong relationships and developing high performing teams.
Debra is a highly skilled leader with over 24 years of experience in clinical research. She started her career as a Statistical Programmer, and subsequently advanced to managerial positions, building and overseeing global teams and developing leadership strategies. In her most recent role as Senior Director of Data Management at a global CRO, Debra provided strategic guidance and operational oversight for a large team of clinical data science professionals.
Debra holds a Bachelor of Arts Degree in Statistics and German from the University of Minnesota, a Master of Business Administration from the University of Saint Thomas and a Certificate in International Business Management from National University of Ireland's Michael Smurfit Graduate Business School.
Having a statistical career spanning all phases of drug development through supporting regulatory submissions, post-submission registries and observational studies, Katherine brings more than 35 years of experience within the pharmaceutical industry to the Veramed team. This is backed by an additional 20+ years in the service sector, where she developed extensive knowledge of operational and client account management, supporting and developing staff in their careers while always keeping client needs at the forefront of decisions.
Katherine achieved a BSc in Mathemetics from Leeds University, followed by an MSc in Applied Statistics from Sheffield Hallam University. An active member of Statisticians in the Pharmaceutical Industry (PSI), she has held positions on their Board of Directors, including a stint as Chair from 2011 to 2012.
Project Based Services
Data Management
Claude is the Senior Director for Data Management at Veramed and has been in the industry for 23 years, during this time Claude has lead teams globally across Biometrics and Data Management. Claude has extensive experience with executing large portfolio's driven towards submission while constantly looking for ways to innovate and onboard new technologies while growing departments to meet the needs of clients.
Claude will have responsibility for managing the Data Management group within Veramed and ensuring that the Data Management teams maintain their excellent standards and helping to grow client governance and maintain regulatory compliance. Claude will work very close with the team members of the Data Management and all other departments helping to enable consistent quality deliverables to all of Veramed's clients.
End-to-End Biometrics
James is an expert Statistical Programmer and Director within the Pharmaceutical space. He has led multiple projects, teams and studies over a wide range of therapeutic areas. James’ ability to innovate and continually develop throughout his career has ensured he has a diverse range of skills spanning team leadership, account management, governance, and technical implementation. James has remained an active programmer throughout and has a keen interest in process improvement. This has led to the development and implementation of various technical solutions and speed-enhancing initiatives such as STDM automation.
He has held previous leadership positions within biometrics, as well as numerous contract positions within statistical programming.
He has held previous leadership positions within biometrics, as well as numerous contract positions within statistical programming.
Integrated Analysis & Submission
With over 25 years of experience in statistical programming, Mark is an expert in integrated analysis and submissions. He leads a global department, bringing his deep expertise in recruitment, business development, and client relations, while maintaining a strong focus on operational and programming support. Mark's hands-on approach ensures the successful delivery of integrated analysis solutions, driving process improvements and supporting system deployment and maintenance. His comprehensive experience enables him to oversee complex analysis workflows and ensure timely, accurate submissions, contributing to the seamless execution of clinical trial projects.
Data Monitoring Committee
Zainab is the head of Veramed's Data Monitoring Committee Business Unit, which provides high quality data analysis centre services to support DMC meetings. She has over 20 years experience as a statistician within the pharmaceutical industry having worked across Phase I-IV and numerous therapeutic areas. Zainab has extensive experience providing statistical support to DMCs as an unblinded statistician and has also served as the expert statistician on DMCs. She has taken the lead on developing and updating SOPs and training to support Veramed's DMC services, including the introduction of specialised training for teams working on DMC projects and hands-on mentoring and workshops for statisticians who perform the independent unblinded statistician role for DMC projects. Zainab has played an instrumental role in growing the DMC business unit, such that Veramed is now a DMC services preferred provider for a number of Top 20 pharmaceutical clients.
Evidence Value Generation
Adam is a seasoned professional with over 25 years of experience in the pharmaceutical and healthcare industries. His expertise lies in unlocking the true value of data and analysis across various business areas, with a particular focus on Real-World Evidence (RWE) generation since 2013. Adam oversaw the delivery of multiple client engagements to unlock value from anonymised patient data.
Adam's expertise in data analysis, RWE generation, and strategic communication makes him a valuable asset in driving innovation and informed decision-making in the healthcare and pharmaceutical sectors.
Adam has held a variety of leadership positions at IQVIA, including Vice President of Real-World Evidence (RWE) for the NEMEA region, where he played a pivotal role in driving the company's RWE portfolio to new heights.
Study Rescue & Rapid Response
Lixin Gao is the founder and President of BioPier Inc., which was acquired by Veramed in 2024. He continues to lead BioPier, LLC, a Veramed U.S. subsidiary, where he manages daily operations with a strong focus on integrated analysis and regulatory submissions. A skilled hands-on leader in the field of biometrics, Lixin is known for his ability to deliver high-quality, timely, and efficient solutions, specializing in fast-track study analysis and regulatory approvals.
Get in touch
Talk to us about your needs
We pride ourselves on providing a perfect service that meets your requirements and is also dynamic to adapt to changes in scope. That’s why we discuss your needs in detail to understand the type of service that will suit you.
